ATCC
New Products Posted to GenomeWeb: Thermo Fisher Scientific, Qiagen, ATCC, DNAStar, More
New products and services posted to GenomeWeb for the week of Oct. 31, 2022.
Researchers and funding organizations are pushing for more diverse cell line and human organoid models for drug discovery and development.
ATCC Inks NCI Biomaterials Processing Contract
ATCC will compete to provide technical support to the the National Cancer Institute's Division of Cancer Epidemiology and Genetics Field and Biospecimen Support Services.
ATCC, Qiagen Ink Bioinformatics Partnership
ATCC will provide sequencing data from cell lines and biological materials to support disease research and drug discovery for Qiagen Digital Insights users.
Crown Bioscience Licenses Cell Line Portfolio From NCI, ATCC
The ATCC deal gives CrownBio access to more than 140 cell lines now and 4,000 cell lines in the future, and the NCI deal gives the firm access to 100 cell lines.
May 31, 2017
ATCC, One Codex Partner on Microbiome Research Tools
Jan 12, 2016
ATCC Licenses CRISPR/Cas9 Tech From Broad Institute
Jan 8, 2014
Biomatrica, ATCC Sign Licensing Deal
Oct 11, 2012
Jan 27, 2011